These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23438652)

  • 21. Muscle strength, body composition, and physical activity in women receiving chemotherapy for breast cancer.
    Visovsky C
    Integr Cancer Ther; 2006 Sep; 5(3):183-91. PubMed ID: 16880422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial.
    Campbell KL; Westerlind KC; Harber VJ; Bell GJ; Mackey JR; Courneya KS
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):731-9. PubMed ID: 17416764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].
    Baba S; Oji Y; Teramoto M; Kawabata K; Saito A
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1905-6. PubMed ID: 19920398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of goserelin treatment in adjuvant therapy for premenopausal patients with breast cancer in Japan-zoladex breast cancer study group trial-B].
    Mitsuyama S; Nomura Y; Ohno S; Miyauchi M; Yamamoto N; Kimura T; Saku M; Miura S; Yoshikawa N; Tsujinaka T; Koh J; Ishida T; Abe O; Ohashi Y
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2071-7. PubMed ID: 16352931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
    Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
    J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can endocrine treatment for hormone-positive premenopausal women with early breast cancer replace adjuvant chemotherapy?
    Malayeri R
    J Clin Oncol; 2003 Jun; 21(12):2444-5; author reply 2446-7. PubMed ID: 12805348
    [No Abstract]   [Full Text] [Related]  

  • 28. [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):111-3. PubMed ID: 20087042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in weight and body composition in women receiving chemotherapy for breast cancer.
    Nissen MJ; Shapiro A; Swenson KK
    Clin Breast Cancer; 2011 Mar; 11(1):52-60. PubMed ID: 21421523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific response of bone to exercise in premenopausal women.
    Winters-Stone KM; Snow CM
    Bone; 2006 Dec; 39(6):1203-9. PubMed ID: 16876495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
    Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
    Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.
    Iwata H; Masuda N; Sagara Y; Kinoshita T; Nakamura S; Yanagita Y; Nishimura R; Iwase H; Kamigaki S; Takei H; Tsuda H; Hayashi N; Noguchi S
    Cancer; 2013 Feb; 119(4):704-13. PubMed ID: 22972694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
    Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet.
    Thomson CA; Rock CL; Giuliano AR; Newton TR; Cui H; Reid PM; Green TL; Alberts DS;
    Eur J Nutr; 2005 Feb; 44(1):18-25. PubMed ID: 15309460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.
    de Haes H; Olschewski M; Kaufmann M; Schumacher M; Jonat W; Sauerbrei W;
    J Clin Oncol; 2003 Dec; 21(24):4510-6. PubMed ID: 14610048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
    Pohl G; Rudas M; Dietze O; Lax S; Markis E; Pirker R; Zielinski CC; Hausmaninger H; Kubista E; Samonigg H; Jakesz R; Filipits M
    J Clin Oncol; 2003 Oct; 21(19):3594-600. PubMed ID: 14512390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise effects on bone mineral density relationships to changes in fitness and fatness.
    Stewart KJ; Bacher AC; Hees PS; Tayback M; Ouyang P; Jan de Beur S
    Am J Prev Med; 2005 Jun; 28(5):453-60. PubMed ID: 15894149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary antiphospholipid syndrome in premenopausal women: low vitamin D, high fat mass and maintained bone mineral mass.
    Paupitz JA; Freire de Carvalho J; Caparbo VF; Klack K; Pereira RM
    Lupus; 2010 Oct; 19(11):1302-6. PubMed ID: 20534647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional fat mobilization and training type on sedentary, premenopausal overweight and obese women.
    Carnero EA; Amati F; Pinto RS; Valamatos MJ; Mil-Homens P; Sardinha LB
    Obesity (Silver Spring); 2014 Jan; 22(1):86-93. PubMed ID: 23836493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.